Cadrenal Therapeutics (CVKD) News Today $11.17 -1.09 (-8.89%) Closing price 04:00 PM EasternExtended Trading$11.80 +0.63 (+5.63%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVKD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD PatientsJune 12, 2025 | finance.yahoo.comCadrenal Therapeutics to Engage Potential Partners at BIO International Convention 2025June 4, 2025 | finance.yahoo.comCVKD: Preparations Continue for Phase 3 Trial of Tecarfarin…May 20, 2025 | msn.comCadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial ReadinessMay 15, 2025 | businesswire.comCadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate UpdateMay 9, 2025 | finance.yahoo.comCadrenal Therapeutics to Present at Inaugural Centri Capital Conference at NasdaqApril 17, 2025 | businesswire.comIs Cadrenal Therapeutics (NASDAQ:CVKD) In A Good Position To Deliver On Growth Plans?April 6, 2025 | finance.yahoo.comCadrenal Therapeutics Participates in Key Medical and Business Development ConferencesApril 3, 2025 | finance.yahoo.comCVKD: Preparing for Phase 3 Trial of Tecarfarin…March 31, 2025 | finance.yahoo.comCadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of TecarfarinMarch 15, 2025 | morningstar.comMNoble Financial Remains a Buy on Cadrenal Therapeutics, Inc. (CVKD)March 14, 2025 | markets.businessinsider.comCadrenal Therapeutics Advances Tecarfarin Development in 2024March 13, 2025 | tipranks.comCVKD: Collaborating with Abbott for Pivotal Phase 3 Trial…March 7, 2025 | msn.comNoble Financial Sticks to Its Buy Rating for Cadrenal Therapeutics, Inc. (CVKD)March 5, 2025 | markets.businessinsider.comCadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVADMarch 4, 2025 | finance.yahoo.comCadrenal Therapeutics teams with Abbott inTECH-LVAD trialMarch 4, 2025 | markets.businessinsider.comQuang X. PhamFebruary 13, 2025 | forbes.comCadrenal Therapeutics Appoints New Chief Medical OfficerFebruary 7, 2025 | tipranks.comCadrenal Therapeutics appoints new chief medical officerFebruary 6, 2025 | msn.comCadrenal Therapeutics Announces Chief Medical Officer Transition to Advance Clinical Development of TecarfarinFebruary 6, 2025 | finance.yahoo.comCadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeedsFebruary 6, 2025 | markets.businessinsider.comCadrenal Therapeutics Announces Chief Medical Officer Transition to Advance Clinical Development of TecarfarinFebruary 6, 2025 | businesswire.comCadrenal Therapeutics to Present at BIO CEO & Investor ConferenceFebruary 6, 2025 | finance.yahoo.comPonte Vedra-based Cadrenal CEO Quang Pham talks biotech, fundingJanuary 22, 2025 | bizjournals.comPonte Vedra biotech firm opens the NASDAQJanuary 13, 2025 | bizjournals.comCadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner MeetingsDecember 18, 2024 | finance.yahoo.comCVKD: Recent Financings Raise $9.8 Million…November 20, 2024 | msn.comCadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech OutlookNovember 19, 2024 | prnewswire.comCadrenal Therapeutics files to sell 590K shares of common stock for holdersNovember 15, 2024 | markets.businessinsider.comCADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESSNovember 12, 2024 | prnewswire.comCadrenal Therapeutics Advances Tecarfarin DevelopmentNovember 9, 2024 | markets.businessinsider.comCADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATENovember 7, 2024 | prnewswire.comCadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross ProceedsNovember 1, 2024 | prnewswire.comWe're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn RateOctober 29, 2024 | finance.yahoo.comPonte Vedra pharmaceutical company raises $5.1 millionOctober 24, 2024 | bizjournals.comCadrenal Therapeutics raises $5.1M via at-the-market facilityOctober 24, 2024 | markets.businessinsider.comCadrenal Therapeutics Raises $5.1 Million for TecarfarinOctober 24, 2024 | markets.businessinsider.comCadrenal Therapeutics Raises $5.1 Million via At-The-Market FacilityOctober 24, 2024 | prnewswire.comCADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUMOctober 23, 2024 | prnewswire.comCadrenal Therapeutics, Inc. (NASDAQ:CVKD) Sees Large Decline in Short InterestOctober 17, 2024 | marketbeat.comCadrenal Therapeutics, Inc. (NASDAQ:CVKD) Shares Sold by Renaissance Technologies LLCOctober 15, 2024 | marketbeat.comCadrenal Therapeutics, Inc. (NASDAQ:CVKD) Sees Significant Increase in Short InterestSeptember 30, 2024 | marketbeat.comCadrenal Therapeutics (NASDAQ:CVKD) Stock, Short Interest ReportSeptember 26, 2024 | benzinga.comCadrenal Therapeutics (NASDAQ:CVKD) Stock Quotes, Forecast and News SummarySeptember 26, 2024 | benzinga.comCadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor ConferenceSeptember 23, 2024 | prnewswire.comZacks Small Cap Comments on Cadrenal Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:CVKD)September 18, 2024 | marketbeat.comCVKD: New Blood Thinner Ready for Phase 3; Initiating Coverage of Cadrenal Therapeutics, Inc…September 16, 2024 | msn.comCadrenal Therapeutics, Inc. (NASDAQ:CVKD) Short Interest UpdateSeptember 12, 2024 | marketbeat.comCadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD PatientsAugust 22, 2024 | prnewswire.comPublished Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD PatientsAugust 20, 2024 | prnewswire.com Get Cadrenal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CVKD and its competitors with MarketBeat's FREE daily newsletter. Email Address CVKD Media Mentions By Week CVKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVKD News Sentiment▼1.870.97▲Average Medical News Sentiment CVKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVKD Articles This Week▼11▲CVKD Articles Average Week Get Cadrenal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CVKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZNTL News Today OPTN News Today CTNM News Today CLYM News Today VXRT News Today BYSI News Today VIRI News Today OCX News Today IPA News Today ABOS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVKD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
